PubMed:25839646 / 98-338 JSONTXT

{"project":"GoldHamster","denotations":[{"id":"T14","span":{"begin":47,"end":59},"obj":"3008"},{"id":"T16","span":{"begin":47,"end":61},"obj":"D016572"},{"id":"T17","span":{"begin":47,"end":61},"obj":"D016572"},{"id":"T19","span":{"begin":63,"end":66},"obj":"PR:Q8CFD5"},{"id":"T20","span":{"begin":63,"end":66},"obj":"PR:000007170"},{"id":"T22","span":{"begin":63,"end":66},"obj":"P08796"},{"id":"T23","span":{"begin":63,"end":66},"obj":"PR:Q13216"},{"id":"T21","span":{"begin":63,"end":66},"obj":"CHEBI:55379"},{"id":"T18","span":{"begin":63,"end":66},"obj":"D003057"},{"id":"T24","span":{"begin":85,"end":89},"obj":"CHEBI:23888"},{"id":"T25","span":{"begin":122,"end":131},"obj":"UBERON:0001353"},{"id":"T26","span":{"begin":132,"end":139},"obj":"GO:0042603"},{"id":"T27","span":{"begin":132,"end":139},"obj":"UBERON:0003893"},{"id":"T28","span":{"begin":132,"end":153},"obj":"D058442"},{"id":"T29","span":{"begin":132,"end":153},"obj":"D058442"},{"id":"T30","span":{"begin":155,"end":158},"obj":"D011085"},{"id":"T31","span":{"begin":174,"end":180},"obj":"UBERON:0003674"},{"id":"T33","span":{"begin":217,"end":220},"obj":"PR:Q8CFD5"},{"id":"T34","span":{"begin":217,"end":220},"obj":"PR:000007170"},{"id":"T36","span":{"begin":217,"end":220},"obj":"P08796"},{"id":"T37","span":{"begin":217,"end":220},"obj":"PR:Q13216"},{"id":"T35","span":{"begin":217,"end":220},"obj":"CHEBI:55379"},{"id":"T32","span":{"begin":217,"end":220},"obj":"D003057"},{"id":"T38","span":{"begin":229,"end":239},"obj":"GO:0008219"}],"text":"The purpose of this study was to determine the Cyclosporine A (CsA) dose and minimum drug delivery time needed to prevent posterior capsule opacification (PCO) in an ex vivo canine model and evaluate the mechanism of CsA-induced cell death."}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T1","span":{"begin":0,"end":240},"obj":"DRI_Approach"}],"text":"The purpose of this study was to determine the Cyclosporine A (CsA) dose and minimum drug delivery time needed to prevent posterior capsule opacification (PCO) in an ex vivo canine model and evaluate the mechanism of CsA-induced cell death."}

{"project":"Goldhamster2_Cellosaurus","denotations":[{"id":"T2","span":{"begin":60,"end":61},"obj":"CVCL_6479|Finite_cell_line|Mus musculus"},{"id":"T3","span":{"begin":99,"end":103},"obj":"CVCL_0047|Telomerase_immortalized_cell_line|Homo sapiens"},{"id":"T4","span":{"begin":163,"end":165},"obj":"CVCL_8754|Cancer_cell_line|Homo sapiens"},{"id":"T5","span":{"begin":163,"end":165},"obj":"CVCL_H241|Cancer_cell_line|Homo sapiens"}],"text":"The purpose of this study was to determine the Cyclosporine A (CsA) dose and minimum drug delivery time needed to prevent posterior capsule opacification (PCO) in an ex vivo canine model and evaluate the mechanism of CsA-induced cell death."}